2023-09-01 2024-08-31 13563809 AZKA PHARMA LTD false 13563809 2023-09-01 2024-08-31 13563809 uk-bus:Director1 2023-09-01 2024-08-31 13563809 uk-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 13563809 uk-bus:SmallEntities 2023-09-01 2024-08-31 13563809 uk-bus:FullAccounts 2023-09-01 2024-08-31 13563809 uk-bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 13563809 2023-09-01 13563809 2024-08-31 13563809 2023-08-31 xbrli:pure iso4217:GBP 13563809 2022-09-01 2023-08-31
Company Registration Number : 13563809 (England and Wales)
13563809
This company is a private limited company
This company sells stuff to other companies
The company was trading for the entire period
Full Accounts
2024-08-31
false
AZKA PHARMA LTD
The accounts were prepared in accordance with FRS102A
The accounts have been audited
2023-09-01
AZKA PHARMA LTD
Unaudited filleted financial statements
For the year ended 31 August 2024
AZKA PHARMA LTD
Contents
For the year ended 31 August 2024

CONTENTS PAGE
Company Information 3
Statement of Financial Position 4
Notes to the Financial Statements 5 - 6


AZKA PHARMA LTD
Company Information
For the year ended 31 August 2024

Company registration number 13563809 (England and Wales)
Director Azka Riaz
Registered office address 38 Rosehill Avenue
Sutton
SM1 3HG
AZKA PHARMA LTD
Statement of Financial Position
For the year ended 31 August 2024

2024 2023
Notes £ £
Fixed assets
Property, plant and equipment 488 -
6 488 -
Current assets
Debtors 2,806 -
Cash and cash equivalents 11,060 22,619
13,866 22,619
Current liabilities
Creditors: Amounts falling due within one year (2,949) (11,190)
Corporation tax payable (1,610) (1,984)
(4,559) (13,174)
Net current assets/(liabilities) 9,307 9,445
Total assets less current liabilities 9,795 9,445
Net assets/(liabilities) 9,795 9,445
Capital and reserves
Called up share capital 100 100
Retained earnings 9,695 9,345
Shareholder's funds 9,795 9,445
For the year ended 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
The directors have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibility for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the special provisions of the Companies Act 2006 applicable to companies subject to the small companies' regime and in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A.
The profit and loss account has not been delivered to the Registrar of Companies in accordance with the special provisions applicable to companies subject to the small entities regime. All the members of the company have consented to the drawing up of the abridged balance sheet.
  • For the year ended 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The director acknowledges their responsibility for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the Board on 07 August 2025
.............................
Azka Riaz (Director)
Company registration number: 13563809
/* == Copy of Frs105 Balance Sheet for XML COntent ============================================================ */
Balance sheet at 2024-08-31 31 August 2024
2024 2023
£ £
Fixed Assets 488 0
Current Assets 13,866 22,619
Creditors: amounts falling due within one year (4,559) (13,174)
Net current assets/(liabilities) 9,307 9,445
Total assets less current liabilities 9,795 9,445
Net Assets/(liabilities) 9,795 9,445
Capital and Reserves 9,795 9,445
For the year ending 31/08/2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. For the year ending 31-08-2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit for the year in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the small companies provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the board of directors on 07 August 2025 2025-08-07 and signed on behalf of the board,
.............................
Azka Riaz
Director
Company registration number: 13563809
AZKA PHARMA LTD
Notes to the Financial Statements
For the year ended 31 August 2024

(1) General Information
The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is 38 Rosehill Avenue, Sutton, SM1 3HG.

(2) Statement of compliance
These individual financial statements have been prepared in accordance with FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A and Companies Act 2006, as applicable to companies subject to the small companies' regime.

(3) Significant Accounting Policies
Basis of Preparation
The financial statements have been prepared on the historical cost basis and in accordance with the Companies Act 2006. The presentation and functional currency of the company is pounds sterling. The financial statements are presented in pound units (£) unless stated otherwise.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. The company recognises revenue when the amount of revenue can be measured reliably, when it is probable that future economic benefits will flow to the entity and when specific criteria have been met as described below.
Sale of goods
Sales of goods are recognised when the company has delivered the goods to the customer, no other significant obligation remains unfulfilled that may affect the customer's acceptance of the products and risks and rewards of ownership have transferred to them.
Rendering of Services
Revenue from provision of services rendered in the reporting period is recognised when the outcome of a transaction for the rendering of services can be estimated reliably in terms of revenue, costs and its stage of completion of the specific transaction at the end of the reporting period. The stage of completion is determined on the basis of the actual completion of a proportion of the total services to be rendered. When the outcome of a service contract cannot be estimated reliably the company only recognises revenue to the extent of the recoverable expenses recognised.
Property, plant and equipment
Property, plant and equipment is stated at cost less accumulated depreciation and impairment losses. Part of an item of property, plant and equipment having different useful lives are accounted for as separate items.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives, using the straight-line method. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis.

Depreciation is provided to write off the cost less estimated residual value, of each asset over its expected useful life as follows:

Asset class and depreciation rate
Land and Buildings
Plant and Machinery
Short Leasehold Properties
Investment Properties
Long Leasehold Properties
Commercial Vehicles
Fixtures and Fittings
Equipment20% straight line
Motor Cars
Taxation
Taxation expense represents the aggregate amount of current tax and deferred tax recognised in the reporting period.
Current Tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit before tax as reported in the income statement because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

(4) Critical accounting judgements and key sources of estimation uncertainty
No judgement
No significant judgements or estimates have been made in preparation of these financial statements.

(5) Employees
During the year, the average number of employees including director was 1 (2023 : 1).

(6) Fixed assets
Tangible

£
Cost
Additions650
As at 31 August 2024650
Depreciation/Amortisation
For the year162
As at 31 August 2024162
Net book value
As at 31 August 2024488
As at 31 August 2023-